This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol 2016; 13: 261-80. doi: 10.1038/nrgastro.2016.51BanalesJMCardinaleVCarpinoGMarzioniMAndersenJBInvernizziPet alExpert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Nat Rev Gastroenterol Hepatol2016132618010.1038/nrgastro.2016.51Open DOISearch in Google Scholar
Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol 2016; 23: 235-43. doi: 10.1245/s10434-015-4642-9SpolveratoGKimYAlexandrescuSMarquesHPLamelasJAldrighettiLet alManagement and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resectionAnn Surg Oncol2016232354310.1245/s10434-015-4642-9Open DOISearch in Google Scholar
Valls C, Gumà A, Puig I, Sanchez A, Andía E, Serrano T, et al. Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 2000; 25: 490-6. doi: 10.1007/s002610000079VallsCGumàAPuigISanchezAAndíaESerranoTet alIntrahepatic peripheral cholangiocarcinoma: CT evaluationAbdom Imaging200025490610.1007/s002610000079Open DOISearch in Google Scholar
Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 2008; 10: 77-82. doi: 10.1080/13651820801992641KhanSAToledanoMBTaylor-RobinsonSDEpidemiology, risk factors, and pathogenesis of cholangiocarcinomaHPB (Oxford)200810778210.1080/13651820801992641Open DOISearch in Google Scholar
Lunsford KE, Javle M, Heyne K, Shroff RT, Abdel-Wahab R, Gupta N, et al. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series. Lancet Gastroenterol Hepatol 2018; 3: 337-48. doi: 10.1016/S2468-1253(18)30045-1LunsfordKEJavleMHeyneKShroffRTAbdel-WahabRGuptaNet alLiver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-seriesLancet Gastroenterol Hepatol201833374810.1016/S2468-1253(18)30045-1Open DOISearch in Google Scholar
Bertuccio P, Malvezzi M, Carioli G, Hashim D, Boffetta P, El-Serag HB, et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol 2019; 71: 104-14. doi: 10.1016/j.jhep.2019.03.013BertuccioPMalvezziMCarioliGHashimDBoffettaPEl-SeragHBet alGlobal trends in mortality from intrahepatic and extrahepatic cholangiocarcinomaJ Hepatol2019711041410.1016/j.jhep.2019.03.01330910538Open DOISearch in Google Scholar
Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014; 60: 1268-89. doi: 10.1016/j.jhep.2014.01.021BridgewaterJGallePRKhanSALlovetJMParkJWPatelTet alGuidelines for the diagnosis and management of intrahepatic cholangiocarcinomaJ Hepatol20146012688910.1016/j.jhep.2014.01.02124681130Open DOISearch in Google Scholar
Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, et al. Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 2011; 31: 49-60. doi: 10.1055/s-0031-1272839SempouxCJibaraGWardSCFanCQinLRoayaieSet alIntrahepatic cholangiocarcinoma: new insights in pathologySemin Liver Dis201131496010.1055/s-0031-127283921344350Open DOISearch in Google Scholar
Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 2003; 10: 288-91. doi: 10.1007/s00534-002-0732-8YamasakiSIntrahepatic cholangiocarcinoma: macroscopic type and stage classificationJ Hepatobiliary Pancreat Surg2003102889110.1007/s00534-002-0732-814598147Open DOISearch in Google Scholar
Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011; 8: 512-22. doi: 10.1038/nrgastro.2011.131BlechaczBKomutaMRoskamsTGoresGJClinical diagnosis and staging of cholangiocarcinomaNat Rev Gastroenterol Hepatol201185122210.1038/nrgastro.2011.131333179121808282Open DOISearch in Google Scholar
Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut 2012; 61: 1657-69. doi: 10.1136/gutjnl-2011-301748KhanSADavidsonBRGoldinRDHeatonNKaraniJPereiraSPet alGuidelines for the diagnosis and treatment of cholangiocarcinoma: an updateGut20126116576910.1136/gutjnl-2011-30174822895392Open DOISearch in Google Scholar
Alvaro D. Serum and bile biomarkers for cholangiocarcinoma. Curr Opin Gastroenterol 2009; 25: 279-84. doi: 10.1097/mog.0b013e328325a894AlvaroDSerum and bile biomarkers for cholangiocarcinomaCurr Opin Gastroenterol2009252798410.1097/mog.0b013e328325a89419396965Open DOISearch in Google Scholar
Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15: 4240-62. doi: 10.3748/wjg.15.4240AljiffryMWalshMJMolinariMAdvances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009World J Gastroenterol20091542406210.3748/wjg.15.4240274418019750567Open DOISearch in Google Scholar
Weber SM, Ribero D, O’Reilly EM, Kokudo N, Miyazaki M, Pawlik TM. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford) 2015; 17: 669-80. doi: 10.1111/hpb.12441WeberSMRiberoDO’ReillyEMKokudoNMiyazakiMPawlikTMIntrahepatic cholangiocarcinoma: expert consensus statementHPB (Oxford)2015176698010.1111/hpb.12441452785226172134Open DOISearch in Google Scholar
Lamarca A, Barriuso J, Chander A, McNamara MG, Hubner RA, ÓReilly D, et al. F-fluorodeoxyglucose positron emission tomography. J Hepatol 2019; 71: 115-29. doi: 10.1016/j.jhep.2019.01.038LamarcaABarriusoJChanderAMcNamaraMGHubnerRAÓReillyDet alF-fluorodeoxyglucose positron emission tomographyJ Hepatol2019711152910.1016/j.jhep.2019.01.03830797051Open DOISearch in Google Scholar
Goodman ZD. Neoplasms of the liver. Mod Pathol 2007; 20(Suppl 1): S49-60. doi: 10.1038/modpathol.3800682GoodmanZDNeoplasms of the liverMod Pathol200720Suppl 1S496010.1038/modpathol.380068217486052Open DOISearch in Google Scholar
Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol 2020; 72: 364-77. doi: 10.1016/j.jhep.2019.11.020MazzaferroVGorgenARoayaieSDrozDit Busset MSapisochinGLiver resection and transplantation for intrahepatic cholangiocarcinomaJ Hepatol2020723647710.1016/j.jhep.2019.11.02031954498Open DOISearch in Google Scholar
Spolverato G, Vitale A, Cucchetti A, Popescu I, Marques HP, Aldrighetti L, et al. Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma? Cancer 2015; 121: 3998-4006. doi: 10.1002/cncr.29619SpolveratoGVitaleACucchettiAPopescuIMarquesHPAldrighettiLet alCan hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?Cancer20151213998400610.1002/cncr.2961926264223Open DOISearch in Google Scholar
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008; 248: 84-96. doi: 10.1097/SLA.0b013e318176c4d3EndoIGonenMYoppACDalalKMZhouQKlimstraDet alIntrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resectionAnn Surg2008248849610.1097/SLA.0b013e318176c4d318580211Open DOISearch in Google Scholar
Tabrizian P, Jibara G, Hechtman JF, Franssen B, Labow DM, Schwartz ME, et al. Outcomes following resection of intrahepatic cholangiocarcinoma. HPB (Oxford) 2015; 17: 344-51. doi: 10.1111/hpb.12359TabrizianPJibaraGHechtmanJFFranssenBLabowDMSchwartzMEet alOutcomes following resection of intrahepatic cholangiocarcinomaHPB (Oxford)2015173445110.1111/hpb.12359436839925395176Open DOISearch in Google Scholar
Zhang XF, Beal EW, Bagante F, Chakedis J, Weiss M, Popescu I, et al. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg 2018; 105: 848-56. doi: 10.1002/bjs.10676ZhangXFBealEWBaganteFChakedisJWeissMPopescuIet alEarly versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intentBr J Surg20181058485610.1002/bjs.10676Open DOISearch in Google Scholar
Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 2001; 193: 384-91. doi: 10.1016/s1072-7515(01)01016-xWeberSMJarnaginWRKlimstraDDeMatteoRPFongYBlumgartLHIntrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomesJ Am Coll Surg20011933849110.1016/s1072-7515(01)01016-xOpen DOISearch in Google Scholar
Patel T. Cholangiocarcinoma – controversies and challenges. Nat Rev Gastroenterol Hepatol 2011; 8: 189-200. doi: 10.1038/nrgastro.2011.20PatelTCholangiocarcinoma – controversies and challengesNat Rev Gastroenterol Hepatol2011818920010.1038/nrgastro.2011.20Open DOISearch in Google Scholar
Goldstein RM, Stone M, Tillery GW, Senzer N, Levy M, Husberg BS, et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 1993; 166: 768-71. doi: 10.1016/s0002-9610(05)80696-8GoldsteinRMStoneMTilleryGWSenzerNLevyMHusbergBSet alIs liver transplantation indicated for cholangiocarcinoma?Am J Surg19931667687110.1016/s0002-9610(05)80696-8Open DOISearch in Google Scholar
Pichlmayr R, Weimann A, Oldhafer KJ, Schlitt HJ, Klempnauer J, Bornscheuer A, et al. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg 1995; 19: 807-13. doi: 10.1007/BF00299775PichlmayrRWeimannAOldhaferKJSchlittHJKlempnauerJBornscheuerAet alRole of liver transplantation in the treatment of unresectable liver cancerWorld J Surg1995198071310.1007/BF002997758553670Open DOISearch in Google Scholar
Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000; 69: 1633-7. doi: 10.1097/00007890-200004270-00019MeyerCGPennIJamesLLiver transplantation for cholangiocarcinoma: results in 207 patientsTransplantation2000691633710.1097/00007890-200004270-0001910836374Open DOISearch in Google Scholar
Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY, et al. iCCA International Consortium. Liver transplantation for “very early” intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment. Hepatology 2016; 64: 1178-88. doi: 10.1002/hep.28744SapisochinGFacciutoMRubbia-BrandtLMartiJMehtaNYaoFYet aliCCA International ConsortiumLiver transplantation for “very early” intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment. Hepatology20166411788810.1002/hep.2874427481548Open DOISearch in Google Scholar
Valle JW, Furuse J, Jitlal M, Beare S, Mizuno N, Wasan H, et al. Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. Ann Oncol 2014; 25: 391-8. doi: 10.1093/annonc/mdt540ValleJWFuruseJJitlalMBeareSMizunoNWasanHet alCisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trialsAnn Oncol201425391810.1093/annonc/mdt54024351397Open DOISearch in Google Scholar
Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 2014; 149: 565-74. doi: 10.1001/ja-masurg.2013.5137MavrosMNEconomopoulosKPAlexiouVGPawlikTMTreatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysisJAMA Surg20141495657410.1001/ja-masurg.2013.5137Open DOISearch in Google Scholar
Wu L, Tsilimigras DI, Paredes AZ, Mehta R, Hyer JM, Merath K, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival. World J Surg 2019; 43: 1777-87. doi: 10.1007/s00268-019-04966-4WuLTsilimigrasDIParedesAZMehtaRHyerJMMerathKet alTrends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survivalWorld J Surg20194317778710.1007/s00268-019-04966-430820734Open DOISearch in Google Scholar
Addeo P, Jedidi I, Locicero A, Faitot F, Oncioiu C, Onea A, et al. Prognostic impact of tumour multinodularity in intrahepatic cholangiocarcinoma. J Gastrointest Surg 2019; 23: 1801-9. doi: 10.1007/s11605-018-4052-yAddeoPJedidiILociceroAFaitotFOncioiuCOneaAet alPrognostic impact of tumour multinodularity in intrahepatic cholangiocarcinomaJ Gastrointest Surg2019231801910.1007/s11605-018-4052-y30478531Open DOISearch in Google Scholar
Le Roy B, Gelli M, Pittau G, Allard MA, Pereira B, Serji B, et al. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma. Br J Surg 2018; 105: 839-47. doi: 10.1002/bjs.10641Le RoyBGelliMPittauGAllardMAPereiraBSerjiBet alNeoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinomaBr J Surg20181058394710.1002/bjs.1064128858392Open DOISearch in Google Scholar
Bosch J, Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Hepatol Int 2018; 12: 1-10. doi: 10.1007/s12072-017-9827-9BoschJIwakiriYThe portal hypertension syndrome: etiology, classification, relevance, and animal modelsHepatol Int20181211010.1007/s12072-017-9827-929064029Open DOISearch in Google Scholar
Si A, Li J, Yang Z, Xia Y, Yang T, Lei Z, et al. Impact of anatomical versus non-anatomical liver resection on short- and long-term outcomes for patients with intrahepatic cholangiocarcinoma. Ann Surg Oncol 2019; 26: 1841-50. doi: 10.1245/s10434-019-07260-8SiALiJYangZXiaYYangTLeiZet alImpact of anatomical versus non-anatomical liver resection on short- and long-term outcomes for patients with intrahepatic cholangiocarcinomaAnn Surg Oncol20192618415010.1245/s10434-019-07260-830843164Open DOISearch in Google Scholar
Reames BN, Ejaz A, Koerkamp BG, Alexandrescu S, Marques HP, Aldrighetti L, et al. Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis. J Surg Oncol 2017; 116: 133-9. doi: 10.1002/jso.24633ReamesBNEjazAKoerkampBGAlexandrescuSMarquesHPAldrighettiLet alImpact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysisJ Surg Oncol2017116133910.1002/jso.2463328411373Open DOISearch in Google Scholar
De Santibañes M, Boccalatte L, de Santibañes E. A literature review of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): so far, so good. Updates Surg 2017; 69: 9-19. doi: 10.1007/s13304-016-0401-0DeSantibañes MBoccalatteLdeSantibañes EA literature review of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): so far, so goodUpdates Surg20176991910.1007/s13304-016-0401-027766595Open DOISearch in Google Scholar
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Hepatobiliary cancers. Version 4.2019. [cited 2019 Dec 27]. Available at https://www.36.org/professionals/physician_gls/pdf/hepatobiliary.pdfNational Comprehensive Cancer NetworkNCCN clinical practice guidelines in oncology. Hepatobiliary cancersVersion 4.2019. [cited 2019 Dec 27]. Available athttps://www.36.org/professionals/physician_gls/pdf/hepatobiliary.pdfSearch in Google Scholar
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 2017; 67: 93-9. doi: 10.3322/caac.21388AminMBGreeneFLEdgeSBComptonCCGershenwaldJEBrooklandRKet alThe eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer stagingCA Cancer J Clin20176793910.3322/caac.2138828094848Open DOISearch in Google Scholar
Sahara K, Tsilimigras DI, Merath K, Bagante F, Guglielmi A, Aldrighetti L, et al. Therapeutic index associated with lymphadenectomy among patients with intrahepatic cholangiocarcinoma: which patients benefit the most from nodal evaluation? Ann Surg Oncol 2019; 26: 2959-68. doi: 10.1245/s10434-019-07483-9SaharaKTsilimigrasDIMerathKBaganteFGuglielmiAAldrighettiLet alTherapeutic index associated with lymphadenectomy among patients with intrahepatic cholangiocarcinoma: which patients benefit the most from nodal evaluation?Ann Surg Oncol20192629596810.1245/s10434-019-07483-931152272Open DOISearch in Google Scholar
Ratti F, Cipriani F, Ariotti R, Gagliano A, Paganelli M, Catena M, et al. Safety and feasibility of laparoscopic liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institution. Surg Endosc 2016; 30: 1999-2010. doi: 10.1097/md.0000000000018307RattiFCiprianiFAriottiRGaglianoAPaganelliMCatenaMet alSafety and feasibility of laparoscopic liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institutionSurg Endosc2016301999201010.1097/md.0000000000018307691951931804378Open DOISearch in Google Scholar
Liu R, Wakabayashi G, Kim HJ, Choi GH, Yiengpruksawan A, Fong Y, et al. International consensus statement on robotic hepatectomy surgery in 2018. World J Gastroenterol 2019; 25: 1432-44. doi: 10.3748/wjg.v25.i12.1432LiuRWakabayashiGKimHJChoiGHYiengpruksawanAFongYet alInternational consensus statement on robotic hepatectomy surgery in 2018World J Gastroenterol20192514324410.3748/wjg.v25.i12.1432644191230948907Open DOISearch in Google Scholar
Spolverato G, Kim Y, Ejaz A, Alexandrescu S, Marques H, Aldrighetti L, et al. Conditional probability of long-term survival after liver resection for Intrahepatic cholangiocarcinoma: a multi-institutional analysis of 535 patients. JAMA Surg 2015; 150: 538-45. doi: 10.1001/jamasurg.2015.0219SpolveratoGKimYEjazAAlexandrescuSMarquesHAldrighettiLet alConditional probability of long-term survival after liver resection for Intrahepatic cholangiocarcinoma: a multi-institutional analysis of 535 patientsJAMA Surg20151505384510.1001/jamasurg.2015.021925831462Open DOISearch in Google Scholar
Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW, et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg 2014; 149: 432-8. doi: 10.1001/jamasurg.2013.5168HyderOMarquesHPulitanoCMarshJWAlexandrescuSBauerTWet alA nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experienceJAMA Surg2014149432810.1001/jamasurg.2013.516824599477Open DOISearch in Google Scholar
Doussot A, Gonen M, Wiggers JK, Groot-Koerkamp B, DeMatteo RP, Fuks D, et al. Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models. J Am Coll Surg 2016; 223: 493-505.e2. doi: 10.1016/j.jamcollsurg.2016.05.019DoussotAGonenMWiggersJKGroot-KoerkampBDeMatteoRPFuksDet alRecurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic modelsJ Am Coll Surg2016223493505e210.1016/j.jamcollsurg.2016.05.019500365227296525Open DOISearch in Google Scholar
Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl. Int 2010; 23: 692-7. doi: 10.1111/j.1432-2277.2010.01108.xRosenCBHeimbachJKGoresGJLiver transplantation for cholangiocarcinomaTranspl. Int201023692710.1111/j.1432-2277.2010.01108.x20497401Open DOISearch in Google Scholar
Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005; 242: 451-61. doi: 10.1097/01.sla.0000179678.13285.faReaDJHeimbachJKRosenCBHaddockMGAlbertsSRKremersWKet alLiver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinomaAnn Surg20052424516110.1097/01.sla.0000179678.13285.fa135775316135931Open DOISearch in Google Scholar
Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Pedersen R, Kremers W, et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006; 82: 1703-7. doi: 10.1097/01.tp.0000253551.43583.d1HeimbachJKGoresGJHaddockMGAlbertsSRPedersenRKremersWet alPredictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinomaTransplantation2006821703710.1097/01.tp.0000253551.43583.d117198263Open DOISearch in Google Scholar
Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 2012; 143: 88-98. doi: 10.1053/j.gastro.2012.04.008DarwishMurad SKimWRHarnoisDMDouglasDDBurtonJKulikLMet alEfficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centersGastroenterology2012143889810.1053/j.gastro.2012.04.008384644322504095Open DOISearch in Google Scholar
Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 2013; 31: 1188-95. doi: 10.1200/JCO.2012.41.5984WangYLiJXiaYGongRWangKYanZet alPrognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomyJ Clin Oncol20133111889510.1200/JCO.2012.41.598423358969Open DOISearch in Google Scholar
Sapisochin G, de Lope CR, Gastaca M, de Urbina JO, López-Andujar R, Palacios F, et al. Intrahepatic cholangiocarcinoma or mixed hepatocellularcholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study. Ann Surg 2014; 259: 944-52. doi: 10.1097/SLA.0000000000000494SapisochinGde LopeCRGastacaMde UrbinaJOLópez-AndujarRPalaciosFet alIntrahepatic cholangiocarcinoma or mixed hepatocellularcholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter studyAnn Surg20142599445210.1097/SLA.000000000000049424441817Open DOISearch in Google Scholar
Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, et al. Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg 2011; 212: 514-20. doi: 10.1016/j.jamcollsurg.2010.12.005HongJCPetrowskyHKaldasFMFarmerDGDurazoFAFinnRSet alPredictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinomaJ Am Coll Surg20112125142010.1016/j.jamcollsurg.2010.12.00521463781Open DOISearch in Google Scholar
Clark CJ, Wood-Wentz CM, Reid-Lombardo KM, Kendrick ML, Huebner M, Que FG. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database. HPB (Oxford) 2011; 13: 612-20. doi: 10.1111/j.1477-2574.2011.00340.xClarkCJWood-WentzCMReid-LombardoKMKendrickMLHuebnerMQueFGLymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER databaseHPB (Oxford)2011136122010.1111/j.1477-2574.2011.00340.xOpen DOISearch in Google Scholar
Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, et al. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 2001; 92: 2374-83. doi: 10.1002/1097-0142(20011101)92:9<2374::aid-cncr1585>3.0.co;2-lOkabayashiTYamamotoJKosugeTShimadaKYamasakiSTakayamaTet alA new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variablesCancer20019223748310.1002/1097-0142(20011101)92:9<2374::aid-cncr1585>3.0.co;2-lOpen DOISearch in Google Scholar
Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009; 16: 14-22. doi: 10.1245/s10434-008-0180-zNathanHAloiaTAVautheyJNAbdallaEKZhuAXSchulickRDet alA proposed staging system for intrahepatic cholangiocarcinomaAnn Surg Oncol200916142210.1245/s10434-008-0180-zOpen DOISearch in Google Scholar
Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, et al. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 2013; 144: 829-40. doi: 10.1053/j.gastro.2013.01.001SiaDHoshidaYVillanuevaARoayaieSFerrerJTabakBet alIntegrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomesGastroenterology20131448294010.1053/j.gastro.2013.01.001Open DOISearch in Google Scholar
Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 2018; 15: 95-111. doi: 10.1038/nrclinonc.2017.157RizviSKhanSAHallemeierCLKelleyRKGoresGJCholangiocarcinoma - evolving concepts and therapeutic strategiesNat Rev Clin Oncol2018159511110.1038/nrclinonc.2017.157Open DOISearch in Google Scholar
Hyder O, Hatzaras I, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery 2013; 153: 811-18. doi: 10.1016/j.surg.2012.12.005HyderOHatzarasISotiropoulosGCPaulAAlexandrescuSMarquesHet alRecurrence after operative management of intrahepatic cholangiocarcinomaSurgery20131538111810.1016/j.surg.2012.12.005Open DOISearch in Google Scholar
Lamarca A, Hubner RA, David Ryder W, Valle JW. Second-line chemotherapy in advanced biliary cancer: a systematic review. Ann Oncol 2014; 25: 2328-38. doi: 10.1093/annonc/mdu162LamarcaAHubnerRADavidRyder WValleJWSecond-line chemotherapy in advanced biliary cancer: a systematic reviewAnn Oncol20142523283810.1093/annonc/mdu162Open DOISearch in Google Scholar
Kim YI, Park JW, Kim BH, Woo SM, Kim TH, Koh YH, et al. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma. Radiat Oncol 2013; 8: 292. doi: 10.1186/1748-717X-8-292KimYIParkJWKimBHWooSMKimTHKohYHet alOutcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinomaRadiat Oncol2013829210.1186/1748-717X-8-292Open DOISearch in Google Scholar
Jackson MW, Amini A, Jones BL, Rusthoven CG, Schefter TE, Goodman KA. Treatment selection and survival outcomes with and without radiation for unresectable, localized intrahepatic cholangiocarcinoma. Cancer J 2016; 22: 237-42. doi: 10.1097/PPO.0000000000000213JacksonMWAminiAJonesBLRusthovenCGSchefterTEGoodmanKATreatment selection and survival outcomes with and without radiation for unresectable, localized intrahepatic cholangiocarcinomaCancer J2016222374210.1097/PPO.0000000000000213Open DOISearch in Google Scholar
Sieghart W, Hucke F, Peck-Radosavljevic M. Transarterial chemoembolization: modalities, indication, and patient selection. J Hepatol 2015; 62: 1187-95. doi: 10.1016/j.jhep.2015.02.010SieghartWHuckeFPeck-RadosavljevicMTransarterial chemoembolization: modalities, indication, and patient selectionJ Hepatol20156211879510.1016/j.jhep.2015.02.010Open DOISearch in Google Scholar
Boehm LM, Jayakrishnan TT, Miura JT, Zacharias AJ, Johnston FM, Turaga KK, et al. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma. J Surg Oncol 2015; 111: 213-20. doi:10.1002/jso.2378BoehmLMJayakrishnanTTMiuraJTZachariasAJJohnstonFMTuragaKKet alComparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinomaJ Surg Oncol20151112132010.1002/jso.2378Open DOISearch in Google Scholar
Hyder O, Marsh JW, Salem R, Petre EN, Kalva S, Liapi E, et al. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma:a multi-institutional analysis. AnnSurg Oncol 2013; 20: 3779-86. doi: 10.1245/s10434-013-3127-yHyderOMarshJWSalemRPetreENKalvaSLiapiEet alIntra-arterial therapy for advanced intrahepatic cholangiocarcinoma:a multi-institutional analysisAnnSurg Oncol20132037798610.1245/s10434-013-3127-y23846786Open DOISearch in Google Scholar
Yang L, Shan J, Shan L, Saxena A, Bester L, Morris DL. Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic review. J Gastrointest Oncol 2015; 6: 570-88. doi: 10.3978/j.issn.2078-6891.2015.055YangLShanJShanLSaxenaABesterLMorrisDLTrans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic reviewJ Gastrointest Oncol201565708810.3978/j.issn.2078-6891.2015.055457091526487951Open DOISearch in Google Scholar
Han K, Ko HK, Kim KW, Won HJ, Shin YM, Kim PN. Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysis. J Vasc Interv Radiol 2015; 26: 943-8. doi: 10.1016/j.jvir.2015.02.024HanKKoHKKimKWWonHJShinYMKimPNRadiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysisJ Vasc Interv Radiol201526943810.1016/j.jvir.2015.02.02425899049Open DOISearch in Google Scholar
Lu Y, Liu L, Wu JC, Bie LK, Gong B. Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: a meta-analysis. Clin Res Hepatol Gastroenterol 2015; 39: 718-24. doi: 10.1016/j.clinre.2014.10.015LuYLiuLWuJCBieLKGongBEfficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: a meta-analysisClin Res Hepatol Gastroenterol2015397182410.1016/j.clinre.2014.10.01526070572Open DOISearch in Google Scholar
